Zugehörigkeit unbekannt
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: the three‐year prospective …
F Tubach, D Salmon, P Ravaud, Y Allanore, P Goupille, M Bréban, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2009
Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci
Groupe Française d'Etude Génétique des Spondylarthrites (GFEGS), ...
Nature genetics 45 (7), 730-738, 2013
Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power Doppler: a cross‐sectional study
MA D'Agostino, R Said‐Nahal, C Hacquard‐Bouder, JL Brasseur, ...
Arthritis & Rheumatism 48 (2), 523-533, 2003
Association between weight or body mass index and hand osteoarthritis: a systematic review
E Yusuf, RG Nelissen, A Ioan-Facsinay, V Stojanovic-Susulic, J DeGroot, ...
Annals of the rheumatic diseases 69 (4), 761-765, 2010
Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases
D Monnet, M Breban, C Hudry, M Dougados, AP Brézin
Ophthalmology 111 (4), 802-809, 2004
Faecal microbiota study reveals specific dysbiosis in spondyloarthritis
M Breban, J Tap, A Leboime, R Said-Nahal, P Langella, G Chiocchia, ...
Annals of the rheumatic diseases 76 (9), 1614-1622, 2017
Double echo steady state magnetic resonance imaging of knee articular cartilage at 3 Tesla: a pilot study for the Osteoarthritis Initiative
F Eckstein, M Hudelmaier, W Wirth, B Kiefer, R Jackson, J Yu, CB Eaton, ...
Annals of the rheumatic diseases 65 (4), 433-441, 2006
Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis
C Wen, Z Zheng, T Shao, L Liu, Z Xie, E Le Chatelier, Z He, W Zhong, ...
Genome biology 18, 1-13, 2017
Three multicenter, randomized, double‐blind, placebo‐controlled studies evaluating the efficacy and safety of ustekinumab in axial spondyloarthritis
A Deodhar, LS Gensler, J Sieper, M Clark, C Calderon, Y Wang, Y Zhou, ...
Arthritis & Rheumatology 71 (2), 258-270, 2019
Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1
A Cortes, SL Pulit, PJ Leo, JJ Pointon, PC Robinson, MH Weisman, ...
Nature communications 6 (1), 7146, 2015
The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients
M Dougados, MA d’Agostino, J Benessiano, F Berenbaum, M Breban, ...
Joint bone spine 78 (6), 598-603, 2011
Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression.
JD Taurog, SD Maika, WA Simmons, M Breban, RE Hammer
Journal of Immunology (Baltimore, Md.: 1950) 150 (9), 4168-4178, 1993
ImmunoChip study implicates antigen presentation to T cells in narcolepsy
J Faraco, L Lin, BR Kornum, EE Kenny, G Trynka, M Einen, TJ Rico, ...
PLoS genetics 9 (2), e1003270, 2013
Efficacy of rituximab in systemic manifestations of primary Sjögren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry
JE Gottenberg, G Cinquetti, C Larroche, B Combe, E Hachulla, O Meyer, ...
Annals of the rheumatic diseases 72 (6), 1026-1031, 2013
T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats.
M Breban, JL Fernández-Sueiro, JA Richardson, RR Hadavand, ...
Journal of immunology (Baltimore, Md.: 1950) 156 (2), 794-803, 1996
Ankylosing spondylitis
A Calin
Clinics in rheumatic diseases 11 (1), 41-60, 1985
Non–TNF-targeted biologic vs a second anti-TNF drug to treat rheumatoid arthritis in patients with insufficient response to a first anti-TNF drug: a randomized clinical trial
JE Gottenberg, O Brocq, A Perdriger, S Lassoued, JM Berthelot, ...
Jama 316 (11), 1172-1180, 2016
Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and …
X Baraliakos, F Heldmann, J Callhoff, J Listing, T Appelboom, J Brandt, ...
Annals of the rheumatic diseases 73 (10), 1819-1825, 2014
Efficacy of infliximab in refractory ankylosing spondylitis: results of a six‐month open‐label study
M Breban, E Vignon, P Claudepierre, V Devauchelle, D Wendling, ...
Rheumatology 41 (11), 1280-1285, 2002
Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment.
M Breban, RE Hammer, JA Richardson, JD Taurog
The Journal of experimental medicine 178 (5), 1607-1616, 1993
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20